Bronchodilator reversibility assessed by spirometry and ventilation imaging in COPD

被引：0
|
作者：
Jeagal, E. [1 ,2 ,3 ]
Alowiwi, H. [2 ,3 ,4 ]
Koltai, H. [5 ]
Rutting, S. [2 ,3 ]
Bailey, E. [6 ]
Willowson, K. [4 ,6 ]
Chapman, D. [1 ,2 ,3 ,7 ]
King, G. [2 ,3 ,7 ,8 ]
机构：
[1] Univ Technol Sydney, Croydon Pk, NSW, Australia
[2] Woolcock Inst Med Res, Airway Physiol & Imaging Grp, Glebe, NSW, Australia
[3] Woolcock Inst Med Res, Woolcock Emphysema Ctr, Glebe, NSW, Australia
[4] Univ Sydney, Fac Sci, Camperdown, NSW, Australia
[5] Univ Sydney, Fac Engn, Camperdown, NSW, Australia
[6] Royal North Shore Hosp, Dept Nucl Med, St Leonards, NSW, Australia
[7] Royal North Shore Hosp, Dept Resp Med, St Leonards, NSW, Australia
[8] Univ Sydney, Fac Med & Hlth, Camperdown, NSW, Australia
来源：
RESPIROLOGY | 2022年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
TP 067
引用
收藏
页码：127 / 127
页数：1
相关论文
共 50 条
  • [41] Bronchodilator reversibility to albuterol predicts bronchodilator response to salmeterol
    Lipworth, BJ
    Jackson, CM
    CHEST, 2002, 121 (04) : 1382 - 1382
  • [42] Respiratory profiles assessed by rest ventilometry predict response to bronchodilator of COPD patients
    Hanusse, P.
    Laveneziana, P.
    Beaufils, F.
    Joie, J.
    Strauss, C.
    Girodet, P.
    Berger, P.
    Similowski, T.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [43] Usefulness of Bronchodilator Reversibility Test Using the Forced Oscillation Technique in Bronchial Asthma, COPD, and Asthma-COPD Overlap
    Nakayasu, H.
    Akamatsu, T.
    Tamura, K.
    Masuda, T.
    Takahashi, S.
    Tanaka, Y.
    Watanabe, H.
    Kishimoto, Y.
    Oishi, K.
    Saigusa, M.
    Yamamoto, A.
    Morita, S.
    Asada, K.
    Shirai, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [44] FEV1 and MRI ventilation defect reversibility in asthma and COPD
    Serajeddini, Hana
    Eddy, Rachel L.
    Licskai, Christopher
    McCormack, David G.
    Parraga, Grace
    EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (03)
  • [45] Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related
    Reid, David W.
    Wen, Yudong
    Johns, David P.
    Williams, Trevor J.
    Ward, Chris
    Walters, E. Haydn
    RESPIROLOGY, 2008, 13 (06) : 799 - 809
  • [46] Acute bronchodilator therapy does not reduce wasted ventilation during exercise in COPD
    Elbehairy, Amany F.
    Webb, Katherine A.
    Laveneziana, Pierantonio
    Domnik, Nicolle J.
    Neder, J. Alberto
    O'Donnell, Denis E.
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2018, 252 : 64 - 71
  • [47] The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD
    Ben Saad, Helmi
    Prefaut, Christian
    Tabka, Zouhair
    Zbidi, Abdelkrim
    Hayot, Maurice
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2008, 21 (05) : 767 - 773
  • [48] Characterization of bronchodilator response by spirometry and plethismography
    Barros, Raquel
    Pinto, Paula
    Barbara, Cristina
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [49] Bronchodilator treatment response mapping in COPD using hyperpolarised gas ventilation MRI
    Horn, Felix
    Marshall, Helen
    Barber, David
    Parra-Robles, Juan
    Lipson, David
    Lawson, Rod
    Wild, Jim
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [50] MEASURES OF VENTILATION DERIVED FROM RADIOGRAPH VELOCIMETRY CORRELATE WITH SPIROMETRY IN PATIENTS WITH COPD
    Khan, Akram
    Brixey, Anu G.
    Ahmed, Cassandra A.
    Krol, Olivia
    Quadri, Suha F.
    Tongpoon, Aaron At
    Hubel, Kinsley A.
    Reddy, Raju M.
    Sowho, Mudiaga
    Fouras, Andreas
    Otvos, Tamas
    Kirkness, Jason
    CHEST, 2022, 162 (04) : 1554A - 1555A
12345